Jobaaj Stories
Eye Care Product Recalls Raise Health Concerns Nationwide
Several major eye care products have been recalled across the United States due to potential contamination, sterility issues, and infection risks. Health experts warn that using these products could lead to serious eye problems, including vision loss or blindness.
AvKARE Recalls Over 1.8 Million Cartons of Eye Drops
AvKARE has issued a nationwide recall of about 1.8 million cartons of eye drops sold between May 26, 2023, and April 21, 2025. The recall follows an FDA inspection, which found that the products may not be sterile — a serious issue for items used in the eyes.
The recalled products include:
-
Artificial Tears Ophthalmic Solution (NDC 50268-043-15)
-
Carboxymethylcellulose Sodium Ophthalmic Gel 1% (NDC 50268-066-15)
-
Carboxymethylcellulose Sodium Ophthalmic Solution (NDC 50268-068-15)
-
Lubricant Eye Drops Solution (NDC 50268-126-15)
-
Polyvinyl Alcohol Ophthalmic Solution (NDC 50268-678-15)
Consumers should stop using these products immediately. Infections caused by contaminated eye drops can be serious and, in some cases, may result in permanent vision damage.
Alcon Recalls Systane Eye Drops After Fungal Contamination Found
On December 21, 2024, Alcon Laboratories voluntarily recalled one lot of its Systane Ultra PF Lubricant Eye Drops (25-count single vials). A customer reported finding foreign material in a sealed vial. Testing confirmed the presence of fungal contamination.
No injuries have been reported, but fungal infections in the eye can be dangerous. If you own this product, check the lot number and return it for a refund or replacement.
FDA Warns Against Over 25 Eye Drop Products
In a broader move, the FDA issued a safety warning in October 2023 about 26 different over-the-counter eye drop products. The brands include:
-
CVS Health
-
Rite Aid
-
Target’s Up & Up
-
Leader and Rugby (Cardinal Health)
-
Velocity Pharma
-
Walmart Equate
These products were linked to insanitary production conditions and bacterial contamination. The FDA advised manufacturers to recall all affected lots, and consumers were urged to stop using and safely discard them.
More Recalls: BRS Analytical and Refresh Products
BRS Analytical Service has also recalled five eye drop solutions after the FDA found multiple safety violations. In addition, Refresh P.M.® and Refresh Lacri-Lube® ointments were pulled from shelves in September 2024 due to defective tube seals. These issues may compromise sterility, especially in long-term use.
What Should You Do If You Have These Products?
-
Stop using the product right away.
-
Check the lot number and expiry date to confirm if your product is affected.
-
Return the product to the store or pharmacy for a refund or exchange.
-
Report any side effects to the FDA through their MedWatch program.
Always consult your eye doctor if you experience redness, pain, blurred vision, or signs of infection.
